Risk factors for a poor outcome after therapy for acute pyelonephritis

BJU International

Volumn 98, Issue 1, 2006, Pages 141-147

  Pertel, Peter E ^a   Haverstock, Daniel ^a  

^a BAYER CORPORATION   (United States)

Author keywords

Acute pyelonephritis; Antibiotic treatment; Outcome; Risk factor; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE;

ACUTE PYELONEPHRITIS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG TREATMENT FAILURE; FEMALE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHROLITHIASIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNIVARIATE ANALYSIS; URINARY TRACT INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DIABETES COMPLICATIONS; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; PYELONEPHRITIS; RISK FACTORS; TREATMENT FAILURE;

EID: 33745107000     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06222.x     Document Type: Article

References (25)

1. Hooton TM Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997 11: 551 81
2. Nicolle LE. Management of acute uncomplicated pyelonephritis. In Bergan T ed., Urinary Tract Infection. Infectiology. Basel: Karger, 1997: 8 13
3. Scholes D Hooton TM Roberts PL Gupta K Stapleton AE Stamm WE. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005 142: 20 7
4. Efstathiou SP Pefanis AV Tsioulos DI et al. Acute pyelonephritis in adults: prediction of mortality and failure of treatment. Arch Intern Med 2003 163: 1206 12
5. Talan DA Stamm WE Hooton TM et al. Comparison of ciprofloxacin (7 days) and trimethprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000 283: 1583 90
6. Talan DA Klimberg IW Nicolle LE Song J Kowalsky SF Church DA. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 2004 171: 734 9
7. Agresti A. Categorical Data Analysis. New York: John Wiley & Sons, 1990
8. McCarty JM Richard G Huck W et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am J Med 1999 106: 292 9
9. Hooton TM Winter C Tiu F Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 1995 273: 41 5
10. Masterton RG Bochsler JA. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J Antimicrob Chemother 1995 35: 129 37
11. Raz R Chazan B Kennes Y et al. Empiric use of trimethoprim- sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002 34: 1165 9
12. McCabe WR Jackson GG. Treatment of pyelonephritis: bacterial, drug and host factors in success or failure among 252 patients. N Engl J Med 1965 272: 1037 44
13. Patterson JE Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1997 11: 735 50
14. Boyko EJ Fihn SD Scholes D Chen CL Normand EH Yarbro P. Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care 2002 25: 1778 83
15. Brown JS Vittinghoff E Kanaya AM et al. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 2001 98: 1045 52
16. Hu KK Boyko EJ Scholes D et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 2004 164: 989 93
17. Geerlings SE Brouwer EC Gaastra W Verhoef J Hoepelman AI. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. J Med Microbiol 1999 48: 535 9
18. Geerlings SE Meiland R van Lith EC Brouwer EC Gaastra W Hoepelman AI. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care 2002 25: 1405 9
19. Geerlings SE Brouwer EC van Kessel KC Gaastra W Stolk RP Hoepelman AI. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 2000 30: 995 1001
20. Hoepelman AI Meiland R Geerlings SE. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 2003 22 ( Suppl. 2 35 43
21. Nicolle LE Friesen D Harding GK Roos LL. Hospitalisation for acute pyelonephritis in Manitoba, Canada, during the period from 1898 to 1992; impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis 1996 22: 1051 6
22. Ronald A Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 2001 17: 287 92
23. Carton JA Maradona JA Nuño FJ Fernandez-Alvarez R Pérez-Gonzalez F Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1992 1: 281 7
24. Huang JJ Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 2000 160: 797 805
25. Griffin MD Bergstralhn EJ Larson TS. Renal papillary necrosis - a sixteen-year clinical experience. J Am Soc Nephrol 1995 6: 248 56